The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Glutathione—a review on its role and significance in Parkinson's disease
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting over a million people in the United States alone, and is characterized by rigidity, bradykinesia, resting tremor, and postural instability. Its main neuropathological feature is the loss of dopaminergic neurons of the substantia nigra pars compacta. However, the pathogenesis of this loss is not understood fully. One of the earliest biochemical changes seen in PD is a reduction in the levels of total glutathione, a key cellular antioxidant. Traditionally, it has been thought that this decrease in GSH levels is the consequence of increased oxidative stress, a process heavily implicated in PD pathogenesis. However, emerging evidence suggests that GSH depletion may itself play an active role in PD pathogenesis. This review aims to explore the contribution of GSH depletion to PD pathogenesis.—Martin, H. L., Teismann, P. Glutathione—a review on its role and significance in Parkinson's disease. FASEB J . 23, 3263–3272 (2009). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Biologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,190
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Clementi, E., Brown, G. C., Feelisch, M., & Moncada, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7631 · Cited by 863 · cited 2×
“This reversibility, especially the photolability, implies that a nitrosothiol group had been formed (54).”
BackgroundMogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
Cellular glutathione and thiols metabolism
Dickinson, D. A., & Forman, H. J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01172-3 · Cited by 851
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Structure of the Hydrophilic Domain of Respiratory Complex I from Thermus thermophilus
Sazanov, L. A., & Hinchliffe, P. (2006) · Science · doi:10.1126/science.1123809 · Cited by 763
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Self-citationExperimental models of Parkinson's disease
Beal, M. F. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072550 · Cited by 637
Wu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Self-citationShen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629
Przedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 590
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 508
Induction of Nitric Oxide Synthase in Glial Cells
Simmons, M. L., & Murphy, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08328.x · Cited by 491
Oxidative stress and aberrant signaling in aging and cognitive decline
Dröge, W., & Schipper, H. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00294.x · Cited by 479
Oxidative Stress in Parkinson's Disease: A Mechanism of Pathogenic and Therapeutic Significance
Zhou, C., Huang, Y., & Przedborski, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.023 · Cited by 450
The pathogenesis of cell death in Parkinson's disease
Jenner, P., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 446
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426
Self-citationOxidative damage in neurodegenerative disease
Jenner, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92347-7 · Cited by 418
Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359
Complex I and Parkinson's Disease
Greenamyre, J. T., Sherer, T. B., Betarbet, R., & Panov, A. V. (2001) · IUBMB Life · doi:10.1080/15216540152845939 · Cited by 337
Brodacki, B., Staszewski, J., Toczyłowska, B., Kozłowska, E., Drela, N., Chalimoniuk, M., & Stępien, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.040 · Cited by 316
Gao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0109fje · Cited by 306
Redox imbalance in Parkinson's disease
Chinta, S. J., & Andersen, J. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.02.005 · Cited by 302
Glutathione peroxidase activity in Parkinson's disease brain
Kish, S. J., Morito, C., & Hornykiewicz, O. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90078-3 · Cited by 299
Glutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296
Neuroinflammatory processes in Parkinson's disease
Hirsch, E. C., Hunot, S., & Hartmann, A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.013 · Cited by 296
Regulation of Ubiquitin-conjugating Enzymes by Glutathione Following Oxidative Stress
Jahngen-Hodge, J., Obin, M. S., Gong, X., Shang, F., Nowell, T. R., Gong, J., Abasi, H., Blumberg, J., & Taylor, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28218 · Cited by 283
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Age-related changes in glutathione and glutathione-related enzymes in rat brain
Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 277
Structural Insights into E1-Catalyzed Ubiquitin Activation and Transfer to Conjugating Enzymes
Lee, I., & Schindelin, H. (2008) · Cell · doi:10.1016/j.cell.2008.05.046 · Cited by 266
Höglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombès, A., Ruberg, M., Friguet, B., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01952.x · Cited by 253
Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity
Jha, N., Jurma, O., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R.-M., Forman, H. J., & Andersen, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000120200 · Cited by 252
N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production
Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S. F., Sironi, M., & Ghezzi, P. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90205-4 · Cited by 236
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., & Di Giovanni, G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 234
Glutathione and Parkinson's disease: Is this the elephant in the room?
Zeevalk, G. D., Razmpour, R., & Bernard, L. P. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.017 · Cited by 212
The pathogenesis of cell death in Parkinson's disease – 2007
Olanow, C. W. (2007) · Movement Disorders · doi:10.1002/mds.21675 · Cited by 211
Oxidative and nitrative protein modifications in Parkinson's disease
Danielson, S. R., & Andersen, J. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.005 · Cited by 202
Dahm, C. C., Moore, K., & Murphy, M. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512203200 · Cited by 194
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Pathogenesis of nigral cell death in Parkinson's disease
Przedborski, S. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.012 · Cited by 183
Reduced intravenous glutathione in the treatment of early parkinson's disease
Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173
Pocernich, C. B., La Fontaine, M., & Butterfield, D. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00126-6 · Cited by 165
Haddad, J. J., & Harb, H. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.029 · Cited by 163
Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151
Offen, D., Gilgun‐Sherki, Y., Barhum, Y., Benhar, M., Grinberg, L. N., Reich, R., Melamed, E., & Atlas, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02428.x · Cited by 138
Chinta, S. J., & Andersen, J. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.002 · Cited by 136
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129
Redox events in interleukin-1 signaling
Brigelius‐Flohé, R., Banning, A., Kny, M., & Böl, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.008 · Cited by 128
Shamoto‐Nagai, M., Maruyama, W., Hashizume, Y., Yoshida, M., Osawa, T., Riederer, P. F., & Naoi, M. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0789-2 · Cited by 127
Anantharam, V., Kaul, S., Song, C., Kanthasamy, A., & Kanthasamy, A. G. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.08.008 · Cited by 122
Hsu, M., Bharath, S., Kumar, J., Rajagopalan, S., & Andersen, J. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02929.x · Cited by 115
Zeevalk, G. D., Manzino, L., Sonsalla, P. K., & Bernard, L. P. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.004 · Cited by 103
Oxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1997) · The Neuroscientist · doi:10.1177/107385849700300112 · Cited by 97
Tarohda, T., Ishida, Y., Kawai, K., Yamamoto, M., & Amano, R. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3423-x · Cited by 95
Oxidative stress indicators are elevated in de novo Parkinson's disease patients.
Ilic, T. V., Jovanovic, M., Jovicic, A., & Tomovic, M. (1999) · PubMed · Cited by 92
Saravanan, K. S., Madathil, S. K., Karuppagounder, S. S., & Mohanakumar, K. P. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.016 · Cited by 92
Oxidative stress on EAAC1 is involved in MPTP‐induced glutathione depletion and motor dysfunction
Aoyama, K., Matsumura, N., Watabe, M., & Nakaki, T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05979.x · Cited by 87
McLellan, L. I., Lewis, A. D., Hall, D. J., Ansell, J. D., & Wolf, C. R. (1995) · Carcinogenesis · doi:10.1093/carcin/16.9.2099 · Cited by 84
Haddad, J. J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00870-x · Cited by 81
Bahat-Stromza, M., Gilgun‐Sherki, Y., Offen, D., Panet, H., Saada, A., Galron-Krool, N., Barzilai, A., Atlas, D., & Melamed, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03889.x · Cited by 76
Glinka, Y., Tipton, K. F., & Youdim, M. B. H. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00279-9 · Cited by 71
Glutathione Depletion in Rats Impairs T-Cell and Macrophage Immune Function
Robinson, M. K. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420130033006 · Cited by 69
Jha, N., Kumar, M. J., Boonplueang, R., & Andersen, J. K. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00009.x · Cited by 64
Bharath, S., & Andersen, J. K. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.900 · Cited by 63
Chinta, S. J., Rajagopalan, S., Butterfield, D. A., & Andersen, J. K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.056 · Cited by 44
Chinta, S. J., Kumar, J., Zhang, H., Forman, H. J., & Andersen, J. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.023 · Cited by 43
Seaton, T. A., Jenner, P. G., & MARSDEN, C. D. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00452-2 · Cited by 33
Caneda-Ferrón, B., Girolamo, L. A. D., Costa, T. C. S., Beck, K. E., Layfield, R., & Billett, E. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05130.x · Cited by 32
Drechsel, D. A., Liang, L., & Patel, M. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.02.002 · Cited by 31
Depletion of glutathione up‐regulates mitochondrial complex I expression in glial cells
Vásquez, O., Almeida, Á., & Bolaños, J. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00223.x · Cited by 26
Kramer, B. C., Yabut, J. A., Cheong, J., JnoBaptiste, R., Robakis, T. K., Olanow, C. W., & Mytilineou, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00310-x · Cited by 22
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 639
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Metadata
- Authors
- Martin, H. L., & Teismann, P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-06-19
- Volume
- 23
- Issue
- 10
- Pages
- 3263-3272
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2168709353
- Cited by
- 314
- References
- 92
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.